Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium

By afschroeder • June 6, 2026

Foeldvari I, Torok KS, Klotsche J, Li JC, Bruni C, Costa-Reis P, Cutolo M, Denton CP, Fligelstone K, Del Galdo F, Gimenez-Roca C, Henes J, Kasapcopur O, Li SC, Marrani E, Orteu CH, Pauling JD, Pilkington C, Ross L, Schonenberg-Meinema D, Furst DE, Smith V. Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium. Expert Rev Clin Immunol. 2026 Jun 5. doi: 10.1080/1744666X.2026.2685050. Epub ahead of print. PMID: 42247287.

Tags: clinical trials, consensus, Disease activity, disease activity index, juvenile systemic sclerosis, outcome measures, pediatric rheumatology, Publications, Rheumatology

Waitlist mortality and post transplant survival amongst non-extracorporeal membrane oxygenation high-urgency heart transplant recipients before and after the 2018 policy change

White JP, Song J, Kim ST, Zappacosta H, Cho PD, McKay S, Girish A, Abramov A, Daniel M, Telesca D, Husain M, Ardehali A. Waitlist[...]

Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart transplant recipients in the United States

Zappacosta H, Daniel M, Tan N, Cho PD, Song J, White JP, Ardehali A. Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart[...]

Results from a Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors

Ganz PA, Van Dyk K, Crespi CM, Petersen L, Sedrak MS, Bower JE. Results from a Phase II Single Arm Trial Evaluating the Safety and[...]